Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

European urology·2026

Same author

[Prevention instead of remediation-screening, lifestyle factors, and prostate care 2.0-transition of urology to healthcare coach : Holistic approach to prostate health].

Urologie (Heidelberg, Germany)·2026

Same author

Impact of Treatment Intensity on Quality of Life in Patients With Metastatic Testicular Cancer.

Andrology·2026

Same author

MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.

European urology oncology·2026

Same author

From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?: Editorial to: Nguyen DD, Tadayon B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. 2026. In press. https://doi.org/10.1016/j.eururo.2026.04.005.

European urology·2026

Same author

[Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?]

Urologie (Heidelberg, Germany)·2026

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Smart Screening in Prostate Cancer: What We Have Learned So Far from PROBASE.

Rouvier Al-Monajjed¹, Agne Krilaviciute², Peter Albers¹

¹Department of Urology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

European Urology Focus

|April 28, 2026

Summary

Smart prostate cancer screening improves detection by using risk stratification, prostate-specific antigen confirmation, MRI, and PSA density-guided biopsy. This approach reduces harm without compromising the identification of significant prostate cancer.

More Related Videos

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Related Experiment Videos

Last Updated: Jun 21, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Area of Science:

Oncology
Medical Imaging
Urology

Background:

Prostate cancer screening aims to detect disease early.
Current screening methods carry risks of overdiagnosis and overtreatment.
Improving screening accuracy and reducing harm are critical.

Purpose of the Study:

To evaluate a "smart" prostate cancer screening strategy.
To determine if enhanced methods can reduce harm while maintaining cancer detection.

Main Methods:

Utilizing risk stratification to identify high-risk individuals.
Employing prostate-specific antigen (PSA) confirmation tests.
Incorporating expert magnetic resonance imaging (MRI) interpretation.
Guiding prostate biopsies using PSA density metrics.

Main Results:

The described "smart" screening approach effectively reduces harm.
Significant prostate cancer detection rates are maintained.
Overdiagnosis and unnecessary biopsies are minimized.

Conclusions:

A multi-faceted "smart" screening strategy enhances prostate cancer detection efficiency.
This optimized approach balances cancer detection with patient safety.
Expert MRI and PSA density are key components for improved prostate cancer diagnosis.